| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dendritic Cells | 31 | 2021 | 2725 | 2.140 |
Why?
|
| Influenza A virus | 6 | 2020 | 456 | 1.990 |
Why?
|
| Antigens, Neoplasm | 20 | 2022 | 1988 | 1.830 |
Why?
|
| Host-Pathogen Interactions | 11 | 2020 | 1480 | 1.630 |
Why?
|
| Single-Cell Analysis | 24 | 2023 | 2182 | 1.500 |
Why?
|
| Immunity | 5 | 2023 | 1014 | 1.250 |
Why?
|
| Antigen Presentation | 12 | 2021 | 1284 | 1.190 |
Why?
|
| Melanoma | 16 | 2023 | 5511 | 1.150 |
Why?
|
| Autoimmune Diseases | 7 | 2022 | 2134 | 1.070 |
Why?
|
| Macrophages | 14 | 2023 | 5660 | 1.060 |
Why?
|
| Immune System | 4 | 2019 | 806 | 1.020 |
Why?
|
| Immunotherapy | 15 | 2024 | 4446 | 0.970 |
Why?
|
| T-Lymphocytes | 19 | 2022 | 10183 | 0.950 |
Why?
|
| CD8-Positive T-Lymphocytes | 14 | 2024 | 4479 | 0.930 |
Why?
|
| Interferon Regulatory Factor-3 | 3 | 2023 | 123 | 0.920 |
Why?
|
| Sequence Analysis, RNA | 18 | 2023 | 2012 | 0.920 |
Why?
|
| Nucleotides, Cyclic | 1 | 2023 | 81 | 0.850 |
Why?
|
| Monocytes | 9 | 2021 | 2596 | 0.830 |
Why?
|
| Neoplasms | 26 | 2023 | 21696 | 0.820 |
Why?
|
| Immunity, Innate | 15 | 2023 | 2962 | 0.810 |
Why?
|
| Legionella pneumophila | 1 | 2021 | 46 | 0.810 |
Why?
|
| Receptors, IgG | 2 | 2022 | 582 | 0.800 |
Why?
|
| Cancer Vaccines | 11 | 2021 | 1023 | 0.790 |
Why?
|
| Cell Nucleus | 4 | 2019 | 2969 | 0.790 |
Why?
|
| Histocompatibility Antigens Class I | 10 | 2023 | 1366 | 0.770 |
Why?
|
| Lupus Nephritis | 5 | 2024 | 310 | 0.760 |
Why?
|
| Epitopes | 9 | 2021 | 2571 | 0.760 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2022 | 1340 | 0.730 |
Why?
|
| Gene Expression Regulation | 21 | 2023 | 12073 | 0.730 |
Why?
|
| Influenza, Human | 3 | 2020 | 1479 | 0.710 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2021 | 315 | 0.700 |
Why?
|
| Membrane Proteins | 9 | 2023 | 7882 | 0.700 |
Why?
|
| Trypanosoma cruzi | 1 | 2021 | 197 | 0.700 |
Why?
|
| Gene Expression Profiling | 24 | 2023 | 9445 | 0.690 |
Why?
|
| RNA, Small Interfering | 17 | 2017 | 3505 | 0.690 |
Why?
|
| Alternative Splicing | 4 | 2021 | 1117 | 0.680 |
Why?
|
| Toll-Like Receptors | 7 | 2018 | 593 | 0.680 |
Why?
|
| Aminopeptidases | 1 | 2018 | 88 | 0.650 |
Why?
|
| Ion Channels | 2 | 2023 | 1056 | 0.650 |
Why?
|
| Sepsis | 3 | 2023 | 2593 | 0.640 |
Why?
|
| Systems Biology | 2 | 2013 | 469 | 0.630 |
Why?
|
| Protons | 1 | 2023 | 1127 | 0.620 |
Why?
|
| Proteomics | 11 | 2024 | 3638 | 0.610 |
Why?
|
| Endodeoxyribonucleases | 2 | 2019 | 165 | 0.610 |
Why?
|
| DNA Damage | 2 | 2019 | 2432 | 0.590 |
Why?
|
| Interferon-gamma | 4 | 2023 | 3207 | 0.590 |
Why?
|
| Computational Biology | 9 | 2022 | 3519 | 0.590 |
Why?
|
| Flow Cytometry | 13 | 2019 | 5974 | 0.550 |
Why?
|
| Signal Transduction | 26 | 2023 | 23404 | 0.530 |
Why?
|
| Virus Replication | 4 | 2020 | 2535 | 0.520 |
Why?
|
| DNA | 5 | 2019 | 7294 | 0.520 |
Why?
|
| Genomics | 10 | 2023 | 5717 | 0.510 |
Why?
|
| Interferon Regulatory Factor-7 | 2 | 2014 | 39 | 0.510 |
Why?
|
| STAT Transcription Factors | 2 | 2023 | 182 | 0.500 |
Why?
|
| Chemokines | 4 | 2024 | 970 | 0.500 |
Why?
|
| Humans | 164 | 2024 | 744366 | 0.480 |
Why?
|
| Peptides | 10 | 2023 | 4410 | 0.480 |
Why?
|
| Cytokines | 10 | 2023 | 7323 | 0.480 |
Why?
|
| Animals | 87 | 2024 | 168768 | 0.480 |
Why?
|
| Quantitative Trait Loci | 7 | 2018 | 2019 | 0.480 |
Why?
|
| Bone Marrow Cells | 7 | 2020 | 2513 | 0.470 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2022 | 17446 | 0.450 |
Why?
|
| Genetic Loci | 3 | 2020 | 2575 | 0.450 |
Why?
|
| HEK293 Cells | 11 | 2023 | 4208 | 0.440 |
Why?
|
| Mice | 63 | 2024 | 81201 | 0.440 |
Why?
|
| Tumor Microenvironment | 9 | 2024 | 3590 | 0.430 |
Why?
|
| Multifactorial Inheritance | 1 | 2020 | 1195 | 0.430 |
Why?
|
| Cell Cycle Proteins | 4 | 2020 | 3464 | 0.420 |
Why?
|
| Genome-Wide Association Study | 10 | 2022 | 12262 | 0.420 |
Why?
|
| Interferon Type I | 5 | 2020 | 542 | 0.410 |
Why?
|
| Colorectal Neoplasms | 6 | 2023 | 6773 | 0.410 |
Why?
|
| Immunogenetics | 1 | 2011 | 67 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 27 | 2021 | 21833 | 0.400 |
Why?
|
| Viruses | 3 | 2013 | 375 | 0.400 |
Why?
|
| Allergy and Immunology | 1 | 2013 | 169 | 0.390 |
Why?
|
| Bacteria | 2 | 2020 | 2115 | 0.370 |
Why?
|
| Mammals | 3 | 2023 | 1143 | 0.360 |
Why?
|
| Interferons | 6 | 2020 | 706 | 0.360 |
Why?
|
| B-Lymphocytes | 9 | 2023 | 4666 | 0.360 |
Why?
|
| Lymphocyte Subsets | 1 | 2011 | 315 | 0.360 |
Why?
|
| Transcription, Genetic | 12 | 2021 | 7721 | 0.360 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2023 | 5172 | 0.350 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 5 | 2021 | 1038 | 0.350 |
Why?
|
| Myeloid Cells | 4 | 2023 | 810 | 0.350 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2012 | 560 | 0.340 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 3 | 2017 | 70 | 0.340 |
Why?
|
| Immune Evasion | 3 | 2023 | 360 | 0.340 |
Why?
|
| Cells, Cultured | 20 | 2021 | 19233 | 0.340 |
Why?
|
| Lymphocyte Activation | 11 | 2021 | 5524 | 0.340 |
Why?
|
| Lectins, C-Type | 2 | 2014 | 589 | 0.340 |
Why?
|
| Fibroblasts | 5 | 2021 | 4162 | 0.340 |
Why?
|
| Melanoma, Experimental | 4 | 2021 | 561 | 0.330 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 7 | 2018 | 1596 | 0.330 |
Why?
|
| Genome | 2 | 2016 | 1807 | 0.330 |
Why?
|
| Nuclear Proteins | 3 | 2020 | 5856 | 0.330 |
Why?
|
| Lipopolysaccharides | 10 | 2021 | 2216 | 0.320 |
Why?
|
| Viral Proteins | 2 | 2020 | 1900 | 0.320 |
Why?
|
| RNA | 8 | 2023 | 2749 | 0.320 |
Why?
|
| Genetic Variation | 8 | 2021 | 6542 | 0.320 |
Why?
|
| Immunologic Memory | 5 | 2021 | 1348 | 0.310 |
Why?
|
| CD4-Positive T-Lymphocytes | 9 | 2023 | 4386 | 0.310 |
Why?
|
| High-Throughput Nucleotide Sequencing | 9 | 2020 | 3595 | 0.310 |
Why?
|
| Proteome | 6 | 2021 | 1798 | 0.310 |
Why?
|
| Antigens | 3 | 2023 | 1466 | 0.310 |
Why?
|
| Cell Line, Tumor | 15 | 2021 | 16690 | 0.300 |
Why?
|
| Cell Communication | 4 | 2023 | 1621 | 0.300 |
Why?
|
| Epitopes, T-Lymphocyte | 4 | 2023 | 880 | 0.300 |
Why?
|
| Interleukin-1beta | 4 | 2023 | 972 | 0.300 |
Why?
|
| Synovial Membrane | 3 | 2019 | 507 | 0.300 |
Why?
|
| Antiviral Agents | 6 | 2023 | 2987 | 0.300 |
Why?
|
| Cell Line | 16 | 2021 | 16000 | 0.300 |
Why?
|
| Gene Regulatory Networks | 7 | 2021 | 1707 | 0.300 |
Why?
|
| Interferon-beta | 3 | 2020 | 324 | 0.290 |
Why?
|
| Lentivirus | 6 | 2014 | 503 | 0.290 |
Why?
|
| Lymph Nodes | 4 | 2023 | 3476 | 0.290 |
Why?
|
| Mass Spectrometry | 3 | 2021 | 2204 | 0.290 |
Why?
|
| Th17 Cells | 4 | 2020 | 766 | 0.290 |
Why?
|
| Inflammation | 7 | 2024 | 10637 | 0.290 |
Why?
|
| RNA Splicing | 4 | 2018 | 908 | 0.290 |
Why?
|
| Epigenesis, Genetic | 6 | 2020 | 3646 | 0.290 |
Why?
|
| Virus Diseases | 1 | 2013 | 711 | 0.280 |
Why?
|
| Insect Proteins | 5 | 1999 | 258 | 0.280 |
Why?
|
| Software | 6 | 2023 | 4441 | 0.280 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2021 | 2917 | 0.280 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2009 | 491 | 0.270 |
Why?
|
| DNA-Binding Proteins | 3 | 2020 | 9647 | 0.270 |
Why?
|
| DNA, Viral | 1 | 2012 | 2227 | 0.270 |
Why?
|
| Kidney | 6 | 2022 | 7184 | 0.270 |
Why?
|
| RNA-Binding Proteins | 5 | 2017 | 1903 | 0.270 |
Why?
|
| Oligosaccharides | 1 | 2008 | 414 | 0.270 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2020 | 3143 | 0.270 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2009 | 459 | 0.260 |
Why?
|
| Mice, Knockout | 17 | 2021 | 14561 | 0.260 |
Why?
|
| Receptors, Antigen, T-Cell | 6 | 2021 | 2540 | 0.260 |
Why?
|
| Gene Expression Regulation, Leukemic | 4 | 2017 | 651 | 0.260 |
Why?
|
| Genetic Techniques | 2 | 2020 | 435 | 0.250 |
Why?
|
| Mice, Transgenic | 11 | 2021 | 9735 | 0.250 |
Why?
|
| Endopeptidases | 2 | 2023 | 772 | 0.250 |
Why?
|
| Autoimmunity | 5 | 2019 | 1350 | 0.250 |
Why?
|
| DNA, Mitochondrial | 2 | 2020 | 817 | 0.240 |
Why?
|
| Methyltransferases | 2 | 2020 | 367 | 0.240 |
Why?
|
| T-Cell Antigen Receptor Specificity | 2 | 2018 | 87 | 0.240 |
Why?
|
| Interleukin-10 | 1 | 2009 | 1200 | 0.240 |
Why?
|
| Immunogenetic Phenomena | 2 | 2015 | 23 | 0.240 |
Why?
|
| Lung Neoplasms | 3 | 2024 | 13104 | 0.240 |
Why?
|
| RNA Interference | 9 | 2016 | 2890 | 0.230 |
Why?
|
| Hepatitis C, Chronic | 2 | 2023 | 1031 | 0.230 |
Why?
|
| Disease Susceptibility | 3 | 2020 | 1782 | 0.230 |
Why?
|
| Killer Cells, Natural | 2 | 2023 | 2133 | 0.230 |
Why?
|
| Mutation | 17 | 2023 | 29786 | 0.230 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5445 | 0.230 |
Why?
|
| Candida albicans | 2 | 2009 | 394 | 0.230 |
Why?
|
| Chemokine CXCL9 | 1 | 2023 | 132 | 0.230 |
Why?
|
| Gene Knockout Techniques | 3 | 2024 | 808 | 0.220 |
Why?
|
| Gene Library | 5 | 2011 | 1074 | 0.220 |
Why?
|
| Receptors, Immunologic | 3 | 2020 | 1423 | 0.220 |
Why?
|
| Receptors, Cell Surface | 4 | 2020 | 2865 | 0.220 |
Why?
|
| Poly I-C | 2 | 2021 | 115 | 0.220 |
Why?
|
| Leukemia, Myeloid | 2 | 2017 | 707 | 0.220 |
Why?
|
| Complementarity Determining Regions | 3 | 2019 | 149 | 0.220 |
Why?
|
| Cross Reactions | 2 | 2021 | 841 | 0.210 |
Why?
|
| Interleukin-16 | 1 | 2022 | 33 | 0.210 |
Why?
|
| Interleukin-18 | 1 | 2023 | 249 | 0.210 |
Why?
|
| Ligands | 4 | 2023 | 3282 | 0.210 |
Why?
|
| Neoplastic Stem Cells | 3 | 2021 | 1376 | 0.210 |
Why?
|
| Models, Genetic | 2 | 2020 | 3493 | 0.210 |
Why?
|
| Pulmonary Alveoli | 2 | 2022 | 675 | 0.210 |
Why?
|
| RNA Viruses | 1 | 2023 | 124 | 0.210 |
Why?
|
| Genome, Human | 6 | 2021 | 4420 | 0.210 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2023 | 144 | 0.200 |
Why?
|
| Golgi Apparatus | 1 | 2023 | 410 | 0.200 |
Why?
|
| Osteopontin | 1 | 2023 | 294 | 0.200 |
Why?
|
| Endosomes | 2 | 2018 | 519 | 0.200 |
Why?
|
| Leukocytes | 5 | 2023 | 2045 | 0.200 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2020 | 2104 | 0.200 |
Why?
|
| Viremia | 2 | 2022 | 736 | 0.200 |
Why?
|
| Neutrophils | 3 | 2023 | 3721 | 0.200 |
Why?
|
| Antibodies, Monoclonal | 2 | 2018 | 9274 | 0.200 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2021 | 91 | 0.200 |
Why?
|
| Vero Cells | 2 | 2020 | 485 | 0.200 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2021 | 565 | 0.190 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2020 | 52 | 0.190 |
Why?
|
| Cell Compartmentation | 1 | 2021 | 402 | 0.190 |
Why?
|
| Thiepins | 1 | 2020 | 5 | 0.190 |
Why?
|
| Dibenzothiepins | 1 | 2020 | 8 | 0.180 |
Why?
|
| Atlases as Topic | 2 | 2021 | 236 | 0.180 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2020 | 56 | 0.180 |
Why?
|
| Neurodegenerative Diseases | 2 | 2023 | 1061 | 0.180 |
Why?
|
| Open Reading Frames | 2 | 2021 | 811 | 0.180 |
Why?
|
| Phosphotransferases | 2 | 2012 | 308 | 0.180 |
Why?
|
| Cell Polarity | 1 | 2023 | 645 | 0.180 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2021 | 534 | 0.180 |
Why?
|
| RNA, Untranslated | 2 | 2021 | 453 | 0.180 |
Why?
|
| Uniparental Disomy | 1 | 2019 | 43 | 0.180 |
Why?
|
| Apoptosis | 6 | 2020 | 9724 | 0.180 |
Why?
|
| Liposomes | 1 | 2023 | 759 | 0.180 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2023 | 2556 | 0.180 |
Why?
|
| High-Throughput Screening Assays | 2 | 2018 | 944 | 0.180 |
Why?
|
| Membrane Glycoproteins | 4 | 2019 | 3771 | 0.180 |
Why?
|
| Organ Specificity | 3 | 2021 | 2008 | 0.180 |
Why?
|
| Epitope Mapping | 1 | 2020 | 311 | 0.170 |
Why?
|
| Endothelial Cells | 3 | 2021 | 3486 | 0.170 |
Why?
|
| Transferrin | 1 | 2020 | 295 | 0.170 |
Why?
|
| Molecular Sequence Annotation | 2 | 2019 | 528 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 8432 | 0.170 |
Why?
|
| Virus Internalization | 2 | 2021 | 502 | 0.170 |
Why?
|
| Endothelium | 1 | 2022 | 778 | 0.170 |
Why?
|
| Mitochondria | 4 | 2021 | 3514 | 0.170 |
Why?
|
| Protein Transport | 4 | 2018 | 1988 | 0.170 |
Why?
|
| Chaperonins | 2 | 2012 | 62 | 0.170 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2012 | 431 | 0.170 |
Why?
|
| P-Selectin | 1 | 2021 | 601 | 0.170 |
Why?
|
| Lipogenesis | 1 | 2020 | 212 | 0.170 |
Why?
|
| Pyridones | 2 | 2023 | 711 | 0.170 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2020 | 121 | 0.170 |
Why?
|
| Hepatitis B, Chronic | 1 | 2023 | 393 | 0.160 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2018 | 49 | 0.160 |
Why?
|
| Models, Immunological | 2 | 2011 | 527 | 0.160 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2019 | 3712 | 0.160 |
Why?
|
| Antigens, CD | 2 | 2020 | 4026 | 0.160 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2020 | 294 | 0.160 |
Why?
|
| T-Lymphocytes, Cytotoxic | 4 | 2023 | 1821 | 0.160 |
Why?
|
| Inflammasomes | 1 | 2023 | 495 | 0.160 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2020 | 323 | 0.160 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2020 | 195 | 0.160 |
Why?
|
| Immunization | 1 | 2023 | 1256 | 0.160 |
Why?
|
| Fibroblast Growth Factors | 3 | 1999 | 878 | 0.160 |
Why?
|
| DNA Mismatch Repair | 1 | 2021 | 426 | 0.160 |
Why?
|
| Oxazines | 1 | 2020 | 298 | 0.160 |
Why?
|
| Jurkat Cells | 5 | 2021 | 743 | 0.160 |
Why?
|
| Head and Neck Neoplasms | 2 | 2023 | 2736 | 0.160 |
Why?
|
| Crohn Disease | 3 | 2020 | 2304 | 0.160 |
Why?
|
| Conserved Sequence | 3 | 2015 | 1202 | 0.160 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 1085 | 0.160 |
Why?
|
| Lysosomes | 2 | 2014 | 893 | 0.150 |
Why?
|
| HLA Antigens | 5 | 2023 | 1382 | 0.150 |
Why?
|
| Human Body | 1 | 2017 | 39 | 0.150 |
Why?
|
| Immunological Synapses | 1 | 2018 | 54 | 0.150 |
Why?
|
| Triazines | 1 | 2020 | 315 | 0.150 |
Why?
|
| Protein Engineering | 1 | 2021 | 538 | 0.150 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2019 | 136 | 0.150 |
Why?
|
| Databases, Protein | 1 | 2019 | 383 | 0.150 |
Why?
|
| Female | 39 | 2022 | 380193 | 0.150 |
Why?
|
| Phagocytes | 2 | 2021 | 297 | 0.150 |
Why?
|
| Hepacivirus | 2 | 2023 | 1379 | 0.150 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2013 | 689 | 0.150 |
Why?
|
| beta Catenin | 2 | 2014 | 1059 | 0.150 |
Why?
|
| Transcription Factors | 8 | 2018 | 12207 | 0.150 |
Why?
|
| Chromatin | 4 | 2020 | 2933 | 0.150 |
Why?
|
| Cytoskeletal Proteins | 2 | 2015 | 1364 | 0.150 |
Why?
|
| Chromosomes | 1 | 2020 | 596 | 0.150 |
Why?
|
| Substrate Specificity | 1 | 2021 | 1802 | 0.150 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 598 | 0.150 |
Why?
|
| DNA Methylation | 4 | 2020 | 4285 | 0.150 |
Why?
|
| Antibodies, Viral | 4 | 2022 | 3177 | 0.150 |
Why?
|
| Escherichia coli | 3 | 2014 | 4217 | 0.150 |
Why?
|
| Hematopoiesis | 4 | 2020 | 2073 | 0.150 |
Why?
|
| Monitoring, Immunologic | 1 | 2017 | 100 | 0.140 |
Why?
|
| beta 2-Microglobulin | 1 | 2017 | 315 | 0.140 |
Why?
|
| Drosophila Proteins | 4 | 1999 | 1703 | 0.140 |
Why?
|
| Response Elements | 1 | 2018 | 312 | 0.140 |
Why?
|
| Classification | 1 | 2017 | 129 | 0.140 |
Why?
|
| Glycolysis | 1 | 2021 | 829 | 0.140 |
Why?
|
| Chromosome Deletion | 2 | 2019 | 1401 | 0.140 |
Why?
|
| Drosophila | 4 | 1999 | 1491 | 0.140 |
Why?
|
| Colonic Polyps | 1 | 2021 | 542 | 0.140 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2020 | 409 | 0.140 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 514 | 0.140 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2020 | 357 | 0.140 |
Why?
|
| Morpholines | 1 | 2020 | 571 | 0.140 |
Why?
|
| Eukaryotic Cells | 1 | 2017 | 198 | 0.140 |
Why?
|
| Cytomegalovirus Infections | 1 | 2023 | 820 | 0.140 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2020 | 780 | 0.140 |
Why?
|
| Antibodies, Neutralizing | 3 | 2021 | 1978 | 0.140 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2021 | 838 | 0.140 |
Why?
|
| Cell Lineage | 5 | 2019 | 2504 | 0.140 |
Why?
|
| Alleles | 7 | 2022 | 6933 | 0.140 |
Why?
|
| Epigenomics | 2 | 2020 | 903 | 0.140 |
Why?
|
| Apyrase | 1 | 2018 | 364 | 0.140 |
Why?
|
| Oncogenes | 2 | 2014 | 1265 | 0.130 |
Why?
|
| Vesiculovirus | 2 | 2012 | 50 | 0.130 |
Why?
|
| Base Sequence | 9 | 2023 | 12797 | 0.130 |
Why?
|
| Stromal Cells | 1 | 2021 | 1355 | 0.130 |
Why?
|
| Virus Release | 1 | 2015 | 39 | 0.130 |
Why?
|
| Metals, Heavy | 1 | 2017 | 139 | 0.130 |
Why?
|
| Gene Silencing | 5 | 2014 | 1539 | 0.130 |
Why?
|
| X Chromosome Inactivation | 1 | 2017 | 224 | 0.130 |
Why?
|
| Lymphocyte Transfusion | 2 | 2013 | 236 | 0.130 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2017 | 209 | 0.130 |
Why?
|
| Databases, Genetic | 4 | 2018 | 1783 | 0.130 |
Why?
|
| Loss of Heterozygosity | 1 | 2017 | 684 | 0.130 |
Why?
|
| Lung | 3 | 2021 | 9857 | 0.130 |
Why?
|
| Thromboembolism | 1 | 2021 | 987 | 0.130 |
Why?
|
| Receptors, Scavenger | 2 | 2020 | 121 | 0.130 |
Why?
|
| Cell Differentiation | 8 | 2021 | 11486 | 0.130 |
Why?
|
| Major Histocompatibility Complex | 1 | 2018 | 936 | 0.130 |
Why?
|
| Linkage Disequilibrium | 1 | 2020 | 1997 | 0.130 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2021 | 1157 | 0.130 |
Why?
|
| Genetic Engineering | 2 | 2014 | 951 | 0.130 |
Why?
|
| Viral Matrix Proteins | 1 | 2015 | 186 | 0.130 |
Why?
|
| Models, Animal | 1 | 2021 | 2173 | 0.130 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 1157 | 0.130 |
Why?
|
| Neoplasms, Experimental | 2 | 2017 | 1276 | 0.120 |
Why?
|
| Genomic Imprinting | 2 | 2019 | 328 | 0.120 |
Why?
|
| Schistosoma | 1 | 2014 | 17 | 0.120 |
Why?
|
| Cohort Studies | 7 | 2021 | 40559 | 0.120 |
Why?
|
| Nephrotic Syndrome | 1 | 2018 | 389 | 0.120 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2014 | 436 | 0.120 |
Why?
|
| Poxviridae Infections | 1 | 2014 | 12 | 0.120 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2015 | 250 | 0.120 |
Why?
|
| Orthopoxvirus | 1 | 2014 | 11 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2013 | 1988 | 0.120 |
Why?
|
| Reproducibility of Results | 8 | 2021 | 19905 | 0.120 |
Why?
|
| Lymphocytes | 2 | 2019 | 2617 | 0.120 |
Why?
|
| Schistosomiasis | 1 | 2014 | 62 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 3 | 2018 | 6386 | 0.120 |
Why?
|
| Phenotype | 10 | 2022 | 16367 | 0.120 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2015 | 172 | 0.120 |
Why?
|
| Endogenous Retroviruses | 1 | 2015 | 112 | 0.120 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2020 | 934 | 0.120 |
Why?
|
| Orthomyxoviridae | 1 | 2015 | 156 | 0.120 |
Why?
|
| Scavenger Receptors, Class F | 1 | 2013 | 16 | 0.120 |
Why?
|
| Protein Multimerization | 1 | 2018 | 971 | 0.110 |
Why?
|
| Drug Industry | 1 | 2020 | 746 | 0.110 |
Why?
|
| Gene Expression | 4 | 2020 | 7798 | 0.110 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 2019 | 1475 | 0.110 |
Why?
|
| Staining and Labeling | 1 | 2018 | 1101 | 0.110 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 743 | 0.110 |
Why?
|
| HMGB2 Protein | 1 | 2012 | 6 | 0.110 |
Why?
|
| Haplotypes | 1 | 2020 | 2779 | 0.110 |
Why?
|
| Body Patterning | 1 | 1998 | 626 | 0.110 |
Why?
|
| Vaccination | 2 | 2023 | 3279 | 0.110 |
Why?
|
| Binding Sites | 1 | 2022 | 6111 | 0.110 |
Why?
|
| Microfluidics | 1 | 2019 | 662 | 0.110 |
Why?
|
| 5' Untranslated Regions | 1 | 2014 | 249 | 0.110 |
Why?
|
| Cell Separation | 1 | 2019 | 1751 | 0.110 |
Why?
|
| Nanowires | 1 | 2012 | 33 | 0.110 |
Why?
|
| Autocrine Communication | 1 | 2014 | 171 | 0.110 |
Why?
|
| Biological Products | 1 | 2022 | 860 | 0.110 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 894 | 0.110 |
Why?
|
| Paracrine Communication | 1 | 2014 | 278 | 0.110 |
Why?
|
| Hepatitis C | 1 | 2023 | 1591 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2022 | 15520 | 0.110 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2015 | 248 | 0.110 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 1236 | 0.110 |
Why?
|
| Ubiquitinated Proteins | 1 | 2012 | 34 | 0.110 |
Why?
|
| Cell Division | 3 | 2020 | 4569 | 0.110 |
Why?
|
| Ribosomes | 1 | 2015 | 500 | 0.110 |
Why?
|
| Membrane Transport Proteins | 1 | 2018 | 1031 | 0.110 |
Why?
|
| Vesicular Stomatitis | 1 | 2012 | 16 | 0.110 |
Why?
|
| Silicon | 1 | 2012 | 145 | 0.100 |
Why?
|
| Protein Phosphatase 2 | 1 | 2014 | 229 | 0.100 |
Why?
|
| Point Mutation | 1 | 2017 | 1624 | 0.100 |
Why?
|
| ROC Curve | 1 | 2020 | 3528 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2023 | 1736 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 4 | 2020 | 4805 | 0.100 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2011 | 354 | 0.100 |
Why?
|
| Models, Biological | 3 | 2021 | 9584 | 0.100 |
Why?
|
| RNA, Messenger | 8 | 2015 | 13035 | 0.100 |
Why?
|
| Lymphocyte Depletion | 1 | 2013 | 608 | 0.100 |
Why?
|
| Metals, Rare Earth | 1 | 2011 | 17 | 0.100 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2019 | 1837 | 0.100 |
Why?
|
| Host-Parasite Interactions | 1 | 2014 | 295 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2019 | 3390 | 0.100 |
Why?
|
| Epithelial Cells | 5 | 2021 | 3690 | 0.100 |
Why?
|
| Transforming Growth Factors | 1 | 2011 | 76 | 0.100 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2011 | 48 | 0.100 |
Why?
|
| rab GTP-Binding Proteins | 2 | 2011 | 246 | 0.100 |
Why?
|
| Proteolipids | 1 | 2011 | 117 | 0.100 |
Why?
|
| Spliceosomes | 1 | 2011 | 110 | 0.100 |
Why?
|
| Immunologic Factors | 3 | 2021 | 1580 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 3 | 2018 | 5867 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2015 | 571 | 0.100 |
Why?
|
| Male | 25 | 2022 | 350115 | 0.100 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2011 | 133 | 0.100 |
Why?
|
| Genetic Testing | 2 | 2018 | 3444 | 0.100 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2011 | 111 | 0.090 |
Why?
|
| Adenocarcinoma | 2 | 2021 | 6364 | 0.090 |
Why?
|
| Colon | 1 | 2019 | 1772 | 0.090 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 1636 | 0.090 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 4851 | 0.090 |
Why?
|
| Young Adult | 7 | 2021 | 56429 | 0.090 |
Why?
|
| Algorithms | 6 | 2020 | 13882 | 0.090 |
Why?
|
| Autophagy | 2 | 2018 | 1297 | 0.090 |
Why?
|
| Necrosis | 1 | 2015 | 1643 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 5223 | 0.090 |
Why?
|
| Skin Neoplasms | 3 | 2022 | 5692 | 0.090 |
Why?
|
| Feedback, Physiological | 2 | 2009 | 479 | 0.090 |
Why?
|
| Synaptotagmins | 1 | 2010 | 59 | 0.090 |
Why?
|
| Chromosome Mapping | 1 | 2018 | 4740 | 0.090 |
Why?
|
| Hair Cells, Auditory | 2 | 1989 | 361 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2018 | 1788 | 0.090 |
Why?
|
| Adult | 16 | 2022 | 214052 | 0.090 |
Why?
|
| Kinetics | 4 | 2022 | 6476 | 0.090 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2012 | 434 | 0.090 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2014 | 1097 | 0.090 |
Why?
|
| Peroxisomes | 1 | 2010 | 58 | 0.090 |
Why?
|
| ras Proteins | 2 | 2014 | 1060 | 0.090 |
Why?
|
| Saccule and Utricle | 1 | 1989 | 81 | 0.090 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2010 | 215 | 0.090 |
Why?
|
| Cytosol | 1 | 2012 | 901 | 0.090 |
Why?
|
| Genetic Vectors | 3 | 2014 | 3424 | 0.090 |
Why?
|
| Antigen-Antibody Complex | 1 | 2011 | 517 | 0.080 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 2760 | 0.080 |
Why?
|
| DNA Copy Number Variations | 2 | 2015 | 1941 | 0.080 |
Why?
|
| Liver | 2 | 2023 | 7475 | 0.080 |
Why?
|
| Protein Binding | 6 | 2021 | 9384 | 0.080 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 464 | 0.080 |
Why?
|
| Janus Kinases | 2 | 2023 | 244 | 0.080 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2009 | 164 | 0.080 |
Why?
|
| Cryptococcus neoformans | 1 | 2009 | 119 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2016 | 1295 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 1968 | 0.080 |
Why?
|
| Benzamides | 1 | 2014 | 1379 | 0.080 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2009 | 241 | 0.080 |
Why?
|
| Natural Killer T-Cells | 1 | 2011 | 316 | 0.080 |
Why?
|
| Myocardium | 1 | 2021 | 4772 | 0.080 |
Why?
|
| Pyridines | 1 | 2020 | 2825 | 0.080 |
Why?
|
| Phagosomes | 1 | 2009 | 193 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2014 | 1602 | 0.080 |
Why?
|
| Colitis, Ulcerative | 1 | 2020 | 1911 | 0.080 |
Why?
|
| Genotype | 1 | 2022 | 12952 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 2 | 2020 | 4463 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 3 | 2020 | 1656 | 0.080 |
Why?
|
| Cell Survival | 5 | 2017 | 5882 | 0.080 |
Why?
|
| RNA, Viral | 2 | 2021 | 2901 | 0.080 |
Why?
|
| Ubiquitination | 1 | 2012 | 1012 | 0.070 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 2126 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2014 | 2505 | 0.070 |
Why?
|
| Renin-Angiotensin System | 2 | 2022 | 758 | 0.070 |
Why?
|
| Adaptive Immunity | 3 | 2021 | 714 | 0.070 |
Why?
|
| Autopsy | 2 | 2021 | 1020 | 0.070 |
Why?
|
| MafB Transcription Factor | 2 | 2017 | 25 | 0.070 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 720 | 0.070 |
Why?
|
| Amino Acid Sequence | 5 | 2021 | 13814 | 0.070 |
Why?
|
| Bacterial Proteins | 3 | 2018 | 3854 | 0.070 |
Why?
|
| Microarray Analysis | 3 | 2019 | 767 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 2200 | 0.070 |
Why?
|
| cdc25 Phosphatases | 1 | 2006 | 62 | 0.070 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 783 | 0.070 |
Why?
|
| Clone Cells | 2 | 2020 | 1692 | 0.070 |
Why?
|
| DNA, Neoplasm | 1 | 2011 | 1758 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 2428 | 0.070 |
Why?
|
| HIV-1 | 3 | 2016 | 6939 | 0.070 |
Why?
|
| Ovalbumin | 1 | 2008 | 719 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 15535 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2014 | 3921 | 0.070 |
Why?
|
| Internet | 1 | 2018 | 3056 | 0.070 |
Why?
|
| Calcium Channels | 1 | 1989 | 622 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 4153 | 0.070 |
Why?
|
| Wnt Proteins | 1 | 2009 | 721 | 0.070 |
Why?
|
| Chromatography, Liquid | 2 | 2021 | 976 | 0.070 |
Why?
|
| Communicable Diseases | 1 | 2014 | 880 | 0.060 |
Why?
|
| Physicians | 1 | 2023 | 4567 | 0.060 |
Why?
|
| Middle Aged | 11 | 2022 | 213390 | 0.060 |
Why?
|
| Exosomes | 1 | 2009 | 417 | 0.060 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2013 | 1271 | 0.060 |
Why?
|
| Molecular Sequence Data | 6 | 2014 | 18111 | 0.060 |
Why?
|
| NF-kappa B | 4 | 2011 | 2499 | 0.060 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 8038 | 0.060 |
Why?
|
| Cluster Analysis | 3 | 2019 | 2715 | 0.060 |
Why?
|
| Disease Progression | 4 | 2021 | 13286 | 0.060 |
Why?
|
| Antigens, Bacterial | 1 | 2010 | 1172 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 14723 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 5263 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2019 | 3524 | 0.060 |
Why?
|
| Antineoplastic Agents | 3 | 2023 | 13693 | 0.060 |
Why?
|
| Immunoblotting | 3 | 2014 | 1683 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2012 | 2441 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3707 | 0.060 |
Why?
|
| Cell Movement | 3 | 2010 | 5218 | 0.060 |
Why?
|
| Ribonucleoproteins | 1 | 2006 | 381 | 0.060 |
Why?
|
| Glioblastoma | 1 | 2018 | 3481 | 0.060 |
Why?
|
| HeLa Cells | 4 | 2011 | 3130 | 0.060 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily C | 1 | 2022 | 32 | 0.060 |
Why?
|
| Respiratory System | 2 | 1996 | 557 | 0.060 |
Why?
|
| Tumor Necrosis Factors | 1 | 2023 | 109 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 1 | 2011 | 2765 | 0.050 |
Why?
|
| Histocompatibility Antigens | 1 | 2023 | 471 | 0.050 |
Why?
|
| Forecasting | 1 | 2011 | 2951 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2020 | 1837 | 0.050 |
Why?
|
| RNA Stability | 2 | 2014 | 321 | 0.050 |
Why?
|
| Histones | 1 | 2013 | 2598 | 0.050 |
Why?
|
| Phagocytosis | 2 | 2013 | 1539 | 0.050 |
Why?
|
| Fetal Blood | 1 | 2009 | 1318 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2725 | 0.050 |
Why?
|
| Immunoprecipitation | 2 | 2015 | 906 | 0.050 |
Why?
|
| Antibodies | 2 | 2021 | 2460 | 0.050 |
Why?
|
| Coronavirus OC43, Human | 1 | 2021 | 18 | 0.050 |
Why?
|
| Isotope Labeling | 2 | 2015 | 406 | 0.050 |
Why?
|
| Viral Load | 2 | 2021 | 3300 | 0.050 |
Why?
|
| Evolution, Molecular | 2 | 2009 | 1939 | 0.050 |
Why?
|
| Chemical Fractionation | 1 | 2021 | 65 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2014 | 2943 | 0.050 |
Why?
|
| Angiotensins | 1 | 2022 | 151 | 0.050 |
Why?
|
| Mannans | 1 | 2001 | 63 | 0.050 |
Why?
|
| Cyclophilins | 1 | 2021 | 46 | 0.050 |
Why?
|
| Trachea | 2 | 1998 | 1076 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2014 | 6194 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 3554 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2015 | 4424 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 4751 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2020 | 2649 | 0.050 |
Why?
|
| Spheroids, Cellular | 1 | 2023 | 351 | 0.050 |
Why?
|
| Proteinuria | 1 | 2024 | 658 | 0.050 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2021 | 124 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 3611 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 1999 | 3617 | 0.050 |
Why?
|
| Cross-Priming | 2 | 2012 | 82 | 0.050 |
Why?
|
| Pyrimidinones | 1 | 2023 | 370 | 0.050 |
Why?
|
| Protein Isoforms | 3 | 2013 | 1730 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2021 | 287 | 0.050 |
Why?
|
| Cell Cycle | 2 | 2006 | 2967 | 0.050 |
Why?
|
| Lymphoid Tissue | 1 | 2002 | 455 | 0.050 |
Why?
|
| Surface-Active Agents | 1 | 2020 | 159 | 0.050 |
Why?
|
| RNA, Double-Stranded | 1 | 2001 | 290 | 0.050 |
Why?
|
| Germinal Center | 1 | 2023 | 377 | 0.050 |
Why?
|
| Renin | 1 | 2022 | 642 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 3037 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2019 | 1335 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 647 | 0.040 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2020 | 53 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2009 | 1418 | 0.040 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2021 | 291 | 0.040 |
Why?
|
| Caspase 1 | 2 | 2011 | 224 | 0.040 |
Why?
|
| Cell Proliferation | 5 | 2016 | 10483 | 0.040 |
Why?
|
| Aged | 9 | 2023 | 163288 | 0.040 |
Why?
|
| Hepatitis B virus | 1 | 2023 | 513 | 0.040 |
Why?
|
| Caspases | 1 | 2023 | 928 | 0.040 |
Why?
|
| Up-Regulation | 4 | 2011 | 4222 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2020 | 409 | 0.040 |
Why?
|
| Calcium | 2 | 1989 | 5755 | 0.040 |
Why?
|
| Mesentery | 1 | 2020 | 205 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2021 | 802 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2020 | 2850 | 0.040 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2010 | 1832 | 0.040 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2020 | 311 | 0.040 |
Why?
|
| Aggression | 1 | 2024 | 753 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2022 | 6313 | 0.040 |
Why?
|
| Transposases | 1 | 2019 | 107 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2022 | 4561 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 995 | 0.040 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2019 | 97 | 0.040 |
Why?
|
| Research Personnel | 1 | 2023 | 573 | 0.040 |
Why?
|
| Enzyme Activation | 3 | 2014 | 3702 | 0.040 |
Why?
|
| Mentors | 1 | 2023 | 631 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2023 | 733 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 712 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 1 | 2022 | 973 | 0.040 |
Why?
|
| Glutathione | 1 | 2021 | 590 | 0.040 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2023 | 428 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2022 | 794 | 0.040 |
Why?
|
| Melanoma-Specific Antigens | 1 | 2018 | 80 | 0.040 |
Why?
|
| Osteochondrodysplasias | 1 | 1999 | 183 | 0.040 |
Why?
|
| U937 Cells | 1 | 2018 | 268 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2021 | 733 | 0.040 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 1888 | 0.040 |
Why?
|
| DNA Modification Methylases | 1 | 2018 | 206 | 0.040 |
Why?
|
| Sirtuins | 1 | 2021 | 323 | 0.040 |
Why?
|
| RNA, Neoplasm | 1 | 2021 | 769 | 0.040 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2023 | 1094 | 0.040 |
Why?
|
| Receptors, Fc | 1 | 2021 | 541 | 0.040 |
Why?
|
| Tumor Escape | 1 | 2020 | 350 | 0.040 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2019 | 421 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 2 | 2011 | 377 | 0.040 |
Why?
|
| Aminoacyltransferases | 1 | 2018 | 51 | 0.040 |
Why?
|
| Melanocytes | 1 | 2021 | 515 | 0.040 |
Why?
|
| Mucins | 1 | 2020 | 564 | 0.040 |
Why?
|
| Leprosy | 1 | 2017 | 124 | 0.040 |
Why?
|
| Restriction Mapping | 1 | 1998 | 878 | 0.040 |
Why?
|
| Automation | 1 | 2020 | 584 | 0.040 |
Why?
|
| Leukemia, Biphenotypic, Acute | 1 | 2017 | 35 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2020 | 576 | 0.040 |
Why?
|
| Databases, Nucleic Acid | 1 | 2018 | 211 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 937 | 0.040 |
Why?
|
| Genes, X-Linked | 1 | 2017 | 128 | 0.040 |
Why?
|
| Drosophila melanogaster | 2 | 1996 | 1708 | 0.040 |
Why?
|
| Activated-Leukocyte Cell Adhesion Molecule | 1 | 2016 | 22 | 0.040 |
Why?
|
| Organoids | 1 | 2023 | 701 | 0.040 |
Why?
|
| DNA Repair Enzymes | 1 | 2018 | 349 | 0.040 |
Why?
|
| Adolescent | 3 | 2021 | 85779 | 0.040 |
Why?
|
| Blood Cells | 1 | 2019 | 309 | 0.040 |
Why?
|
| Prognosis | 3 | 2023 | 29060 | 0.040 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2017 | 111 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2020 | 1950 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2002 | 1158 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 2019 | 634 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2010 | 5023 | 0.030 |
Why?
|
| Protein Stability | 1 | 2018 | 556 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2016 | 3001 | 0.030 |
Why?
|
| Sulfotransferases | 1 | 2016 | 151 | 0.030 |
Why?
|
| Cell Death | 1 | 2021 | 1707 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 2018 | 4320 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2019 | 659 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2016 | 71 | 0.030 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1996 | 185 | 0.030 |
Why?
|
| CD40 Ligand | 1 | 2018 | 526 | 0.030 |
Why?
|
| Chromosomes, Human, X | 1 | 2017 | 296 | 0.030 |
Why?
|
| Phosphorylation | 3 | 2017 | 8436 | 0.030 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2018 | 323 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 711 | 0.030 |
Why?
|
| Interferon Regulatory Factors | 1 | 2017 | 270 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 57776 | 0.030 |
Why?
|
| Antibody Formation | 1 | 2020 | 1402 | 0.030 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2016 | 106 | 0.030 |
Why?
|
| Hexosyltransferases | 1 | 2015 | 53 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 18034 | 0.030 |
Why?
|
| Ascites | 1 | 2017 | 344 | 0.030 |
Why?
|
| Transduction, Genetic | 2 | 2009 | 913 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 2018 | 563 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 3773 | 0.030 |
Why?
|
| Adipocytes | 1 | 2002 | 1185 | 0.030 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2015 | 159 | 0.030 |
Why?
|
| Tristetraprolin | 1 | 2014 | 42 | 0.030 |
Why?
|
| Microglia | 1 | 2023 | 1267 | 0.030 |
Why?
|
| Sulfites | 1 | 2014 | 78 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2021 | 1904 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2021 | 1533 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2009 | 3749 | 0.030 |
Why?
|
| Receptors, CCR5 | 1 | 2016 | 498 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2017 | 475 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2019 | 1880 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2021 | 3689 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1998 | 2050 | 0.030 |
Why?
|
| Workflow | 1 | 2019 | 847 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2011 | 1369 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2016 | 1783 | 0.030 |
Why?
|
| Rheumatic Fever | 1 | 2014 | 71 | 0.030 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2014 | 146 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2015 | 320 | 0.030 |
Why?
|
| STAT2 Transcription Factor | 1 | 2013 | 27 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2014 | 356 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2014 | 203 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2018 | 670 | 0.030 |
Why?
|
| Mutation, Missense | 2 | 2014 | 2566 | 0.030 |
Why?
|
| Mice, Inbred CBA | 1 | 2014 | 448 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2014 | 209 | 0.030 |
Why?
|
| Complement C1q | 1 | 2013 | 92 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2012 | 5181 | 0.030 |
Why?
|
| Rana catesbeiana | 2 | 1989 | 86 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2014 | 225 | 0.030 |
Why?
|
| Cadherins | 1 | 2018 | 907 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 418 | 0.030 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2012 | 64 | 0.030 |
Why?
|
| RGS Proteins | 1 | 2013 | 77 | 0.030 |
Why?
|
| Antioxidants | 1 | 2021 | 1659 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2023 | 2043 | 0.030 |
Why?
|
| Interleukin-23 | 1 | 2014 | 194 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2023 | 5534 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 1999 | 1660 | 0.030 |
Why?
|
| Ploidies | 1 | 2013 | 281 | 0.030 |
Why?
|
| Lymphotoxin alpha1, beta2 Heterotrimer | 1 | 2012 | 3 | 0.030 |
Why?
|
| Iodoacetamide | 1 | 2012 | 35 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 480 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2020 | 4010 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2013 | 151 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2016 | 805 | 0.030 |
Why?
|
| Immunohistochemistry | 3 | 2020 | 11366 | 0.030 |
Why?
|
| Thiocyanates | 1 | 2012 | 70 | 0.030 |
Why?
|
| Nephritis | 1 | 2013 | 159 | 0.030 |
Why?
|
| Leupeptins | 1 | 2012 | 122 | 0.030 |
Why?
|
| Regeneration | 1 | 2021 | 1485 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 1146 | 0.030 |
Why?
|
| Semiconductors | 1 | 2013 | 105 | 0.030 |
Why?
|
| Polyubiquitin | 1 | 2012 | 70 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 697 | 0.030 |
Why?
|
| Activin Receptors, Type I | 1 | 2012 | 142 | 0.030 |
Why?
|
| Granuloma | 1 | 2014 | 319 | 0.030 |
Why?
|
| Alkylating Agents | 1 | 2012 | 139 | 0.030 |
Why?
|
| Genetic Pleiotropy | 1 | 2013 | 182 | 0.030 |
Why?
|
| Blood Donors | 1 | 2013 | 355 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2018 | 2560 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2013 | 793 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2018 | 1951 | 0.020 |
Why?
|
| Chemokine CCL3 | 1 | 2011 | 84 | 0.020 |
Why?
|
| Methylation | 1 | 2014 | 1106 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 2011 | 223 | 0.020 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2011 | 143 | 0.020 |
Why?
|
| Survivors | 1 | 2021 | 2291 | 0.020 |
Why?
|
| Multigene Family | 1 | 2014 | 1102 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 940 | 0.020 |
Why?
|
| International Cooperation | 1 | 2017 | 1420 | 0.020 |
Why?
|
| Biotinylation | 1 | 2011 | 179 | 0.020 |
Why?
|
| Adenoma | 1 | 2021 | 2174 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2022 | 2569 | 0.020 |
Why?
|
| Antigens, CD1d | 1 | 2011 | 220 | 0.020 |
Why?
|
| Synaptotagmin II | 1 | 2010 | 15 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2011 | 417 | 0.020 |
Why?
|
| CpG Islands | 1 | 2014 | 1170 | 0.020 |
Why?
|
| HIV Infections | 1 | 2016 | 16715 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2018 | 2307 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2013 | 1828 | 0.020 |
Why?
|
| vif Gene Products, Human Immunodeficiency Virus | 1 | 2010 | 53 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2014 | 1035 | 0.020 |
Why?
|
| Chemokine CXCL10 | 1 | 2011 | 305 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2015 | 934 | 0.020 |
Why?
|
| Leukemia, T-Cell | 1 | 2010 | 104 | 0.020 |
Why?
|
| Serine | 1 | 2013 | 826 | 0.020 |
Why?
|
| Placenta | 1 | 2018 | 1699 | 0.020 |
Why?
|
| Lipopeptides | 1 | 2009 | 75 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2017 | 1099 | 0.020 |
Why?
|
| DNA Primers | 1 | 2014 | 2891 | 0.020 |
Why?
|
| Pregnancy | 3 | 2019 | 29144 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 1989 | 411 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 547 | 0.020 |
Why?
|
| Amino Acids | 1 | 2015 | 1737 | 0.020 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2010 | 156 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 994 | 0.020 |
Why?
|
| DNA, Intergenic | 1 | 2009 | 107 | 0.020 |
Why?
|
| Nucleic Acids | 1 | 2011 | 182 | 0.020 |
Why?
|
| Morphogenesis | 3 | 1996 | 751 | 0.020 |
Why?
|
| Cryptococcosis | 1 | 2009 | 101 | 0.020 |
Why?
|
| Aminopyridines | 1 | 2012 | 542 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 2700 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2012 | 791 | 0.020 |
Why?
|
| Chemokine CXCL12 | 1 | 2010 | 465 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2013 | 1915 | 0.020 |
Why?
|
| Spleen | 1 | 2014 | 2362 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 1 | 2008 | 259 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 1607 | 0.020 |
Why?
|
| DNA, Single-Stranded | 1 | 2009 | 355 | 0.020 |
Why?
|
| Heart | 1 | 2021 | 4464 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 2418 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2014 | 828 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 1341 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1996 | 2455 | 0.020 |
Why?
|
| Cell Adhesion | 2 | 2009 | 3144 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2008 | 821 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2015 | 1678 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6755 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2010 | 607 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 1547 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2011 | 550 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 4185 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 1525 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2021 | 53290 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2011 | 895 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2015 | 2036 | 0.020 |
Why?
|
| Libraries | 1 | 2006 | 21 | 0.020 |
Why?
|
| Immunomodulation | 1 | 2010 | 541 | 0.020 |
Why?
|
| Candidiasis | 1 | 2009 | 366 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2017 | 3024 | 0.020 |
Why?
|
| G2 Phase | 1 | 2006 | 139 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 1862 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2009 | 560 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2015 | 6459 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 1989 | 1137 | 0.020 |
Why?
|
| Receptors, CXCR4 | 1 | 2010 | 727 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2006 | 1085 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2009 | 634 | 0.020 |
Why?
|
| Brain | 2 | 2023 | 26388 | 0.020 |
Why?
|
| Epithelium | 1 | 1989 | 1679 | 0.020 |
Why?
|
| Endopeptidase K | 1 | 2004 | 23 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 2008 | 674 | 0.020 |
Why?
|
| Polymyxin B | 1 | 2004 | 46 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2009 | 1879 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2006 | 980 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2014 | 3203 | 0.010 |
Why?
|
| Chaperonin 60 | 1 | 2004 | 103 | 0.010 |
Why?
|
| Reference Values | 1 | 2011 | 4982 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2004 | 370 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2009 | 2716 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2010 | 1211 | 0.010 |
Why?
|
| Zebrafish | 1 | 2014 | 2996 | 0.010 |
Why?
|
| Exons | 1 | 2009 | 2439 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2004 | 964 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18373 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 4777 | 0.010 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2009 | 852 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 1989 | 1312 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11525 | 0.010 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2002 | 250 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2021 | 63107 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 2703 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2011 | 2241 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 2076 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2002 | 438 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8385 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2011 | 5451 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 2383 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6171 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2002 | 275 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 1101 | 0.010 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2002 | 440 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2014 | 2775 | 0.010 |
Why?
|
| Ethyl Methanesulfonate | 1 | 1999 | 29 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2012 | 5096 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2014 | 3079 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 9240 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 2916 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1999 | 719 | 0.010 |
Why?
|
| Transfection | 1 | 2006 | 5895 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 25039 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1999 | 982 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1996 | 829 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2009 | 10252 | 0.010 |
Why?
|
| Heat-Shock Response | 1 | 1996 | 165 | 0.010 |
Why?
|
| Nervous System | 1 | 1999 | 554 | 0.010 |
Why?
|
| Eye Proteins | 1 | 1999 | 645 | 0.010 |
Why?
|
| Species Specificity | 1 | 1999 | 2478 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1999 | 1264 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 2839 | 0.010 |
Why?
|
| Eye | 1 | 1999 | 729 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 1996 | 583 | 0.010 |
Why?
|
| Risk | 1 | 2006 | 9688 | 0.010 |
Why?
|
| Extremities | 1 | 1999 | 866 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1996 | 1723 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 1996 | 927 | 0.010 |
Why?
|
| Cell Count | 1 | 1996 | 1856 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1996 | 1536 | 0.010 |
Why?
|
| United States | 1 | 2020 | 69872 | 0.010 |
Why?
|
| Child | 1 | 2019 | 77709 | 0.010 |
Why?
|
| Time Factors | 2 | 1989 | 40075 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 10943 | 0.010 |
Why?
|
| Stem Cells | 1 | 2002 | 3567 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2002 | 3864 | 0.000 |
Why?
|
| Insulin | 1 | 2002 | 6582 | 0.000 |
Why?
|
| Movement | 1 | 1989 | 1471 | 0.000 |
Why?
|